Publisher
Springer Science and Business Media LLC
Reference34 articles.
1. Rej S, Elie D, Mucsi I, et al. Chronic kidney disease in lithium-treated older adults: a review of epidemiology, mechanisms, and implications for the treatment of late-life mood disorders. Drugs Aging. 2015;32(1):31–42.
2. Grof P. Sixty years of lithium responders. Neuropsychobiology. 2010;62(1):8–16.
3. Shulman KI, Rochon P, Sykora K, et al. Changing prescription patterns for lithium and valproic acid in old age: shifting practice without evidence. BMJ. 2003;326(7396):960.
4. National quality use of medicines indicators for Australian hospitals. Sydney: Australian Commission on Safety and Quality in Health Care and NSW Therapeutic Advisory Group Inc.; 2014.
5. Crowe E, Halpin D, Stevens P. Early identification and management of chronic kidney disease: summary of NICE guidance. Guideline Development Group. BMJ. 2008;2008(337):a1530.